Cargando…

RON in hepatobiliary and pancreatic cancers: Pathogenesis and potential therapeutic targets

The receptor protein tyrosine kinase RON belongs to the c-MET proto-oncogene family. Research has shown that RON has a role in cancer pathogenesis, which places RON on the frontline of the development of novel cancer therapeutic strategies. Hepatobiliary and pancreatic (HBP) cancers have a poor prog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Shao-Long, Wang, Guo-Ping, Shi, Dan-Rong, Yao, Shu-Hao, Chen, Ke-Da, Yao, Hang-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160627/ https://www.ncbi.nlm.nih.gov/pubmed/34092972 http://dx.doi.org/10.3748/wjg.v27.i20.2507

Ejemplares similares

Hepatobiliary and pancreatic ascariasis
por: Khuroo, Mohammad S, et al.
Publicado: (2016)

Role of artificial intelligence in hepatobiliary and pancreatic surgery
por: Bari, Hassaan, et al.
Publicado: (2021)

Adipose-derived stem cells in the treatment of hepatobiliary diseases and sepsis
por: Satilmis, Basri, et al.
Publicado: (2022)

Role of innovative 3D printing models in the management of hepatobiliary malignancies
por: Bangeas, Peter, et al.
Publicado: (2019)

Acute and chronic hepatobiliary manifestations of sickle cell disease: A review
por: Shah, Rushikesh, et al.
Publicado: (2017)

Pathogenesis of RON receptor tyrosine kinase in cancer cells: activation mechanism, functional crosstalk, and signaling addiction
por: Wang, Ming-Hai, et al.
Publicado: (2013)

Pathogenesis of autoimmune hepatitis
por: Fan, Jun-Hua, et al.
Publicado: (2021)

Significance of the entire C-terminus in biological activities mediated by the RON receptor tyrosine kinase and its oncogenic variant RON160
por: Lu, Yi, et al.
Publicado: (2008)

Therapeutic plasma exchange for hyperlipidemic pancreatitis: Current evidence and unmet needs
por: Zheng, Can-Bin, et al.
Publicado: (2021)

Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Pancreatic Cancer
por: Hu, Chen-Yu, et al.
Publicado: (2019)

Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases
por: Wang, Jing-Hua
Publicado: (2023)

Gaseous metabolites as therapeutic targets in ulcerative colitis
por: Yao, Chu K, et al.
Publicado: (2023)

Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy via the gut-liver-brain axis
por: Luo, Ming, et al.
Publicado: (2023)

Gut microbiota and diabetic kidney diseases: Pathogenesis and therapeutic perspectives
por: Lin, Jia-Ran, et al.
Publicado: (2022)

RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative Breast Cancer
por: Weng, Tian-Hao, et al.
Publicado: (2020)

Golgi Stress Response: New Insights into the Pathogenesis and Therapeutic Targets of Human Diseases
por: Kim, Won Kyu, et al.
Publicado: (2023)

Novel mechanism of hepatobiliary system damage and immunoglobulin G4 elevation caused by Clonorchis sinensis infection
por: Zhang, Xin-He, et al.
Publicado: (2021)

Liver injury in COVID-19: Detection, pathogenesis, and treatment
por: Cai, Yue, et al.
Publicado: (2021)

Molecular therapeutic strategies targeting pancreatic cancer induced cachexia
por: Yakovenko, Anastasiya, et al.
Publicado: (2018)

Research advances of vasoactive intestinal peptide in the pathogenesis of ulcerative colitis by regulating interleukin-10 expression in regulatory B cells
por: Sun, Xiong, et al.
Publicado: (2020)

Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer
por: Elaskalani, Omar, et al.
Publicado: (2017)

Exploiting inflammation for therapeutic gain in pancreatic cancer
por: Steele, C W, et al.
Publicado: (2013)

Advancements of molecular imaging and radiomics in pancreatic carcinoma
por: Pang, Xiao-Xi, et al.
Publicado: (2023)

Pancreatic cancer stem cells: Perspectives on potential therapeutic approaches of pancreatic ductal adenocarcinoma
por: Di Carlo, Claudia, et al.
Publicado: (2018)

Ron Knockdown and Ron Monoclonal Antibody IMC-RON8 Sensitize Pancreatic Cancer to Histone Deacetylase Inhibitors (HDACi)
por: Zou, Yi, et al.
Publicado: (2013)

Go-Ichi-Ni-San 2: A potential biomarker and therapeutic target in human cancers
por: Shan, Dan-Dan, et al.
Publicado: (2022)

Latest therapeutic target for gastric cancer: Anthrax toxin receptor 1
por: Sun, Ke-Ran, et al.
Publicado: (2021)

Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy
por: Tong, Xiang-Min, et al.
Publicado: (2019)

Current and emerging therapeutic strategies in pancreatic cancer: Challenges and opportunities
por: Manrai, Manish, et al.
Publicado: (2021)

Characterization of RON protein isoforms in pancreatic cancer: implications for biology and therapeutics
por: Chakedis, Jeffery, et al.
Publicado: (2016)

Surgical intervention for acute pancreatitis in the COVID-19 era
por: Su, Yu-Jang, et al.
Publicado: (2022)

Updated review on immune factors in pathogenesis of Crohn’s disease
por: Li, Na, et al.
Publicado: (2018)

Anti-tumor effect of statin on pancreatic adenocarcinoma: From concept to precision medicine
por: Huang, Chung-Tsui, et al.
Publicado: (2021)

MET and RON receptor tyrosine kinases in colorectal adenocarcinoma: molecular features as drug targets and antibody-drug conjugates for therapy
por: Yao, Hang-Ping, et al.
Publicado: (2020)

Pathogenesis and clinical management of Helicobacter pylori gastric infection
por: de Brito, Breno Bittencourt, et al.
Publicado: (2019)

Recent advances in the diagnostic evaluation of pancreatic cystic lesions
por: Ardeshna, Devarshi R, et al.
Publicado: (2022)

Autophagy in viral replication and pathogenesis
por: Sir, Donna, et al.
Publicado: (2010)

Pathogenesis, clinical manifestations, diagnosis, and treatment progress of achalasia of cardia
por: Li, Ming-Yue, et al.
Publicado: (2023)

The monoclonal antibody Zt/f2 targeting RON receptor tyrosine kinase as potential therapeutics against tumor growth-mediated by colon cancer cells
por: Yao, Hang-Ping, et al.
Publicado: (2011)

ARF-BP1 as a potential therapeutic target
por: Chen, D, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_9mbv36or1lbrh0h9ciqvejf2ct